Published Date: 08 Mar 2023
At a trial in Georgia on Wednesday, three drug traffickers won a case brought by the family of a drug addict, accusing the company of selling drugs.
Read Full NewsFor more than a year, Diane Hunter, now 72, had been experiencing vague symptoms—pain in her spine and hips, nausea, exhaustion, thirst, and frequent urination. Her primary care physician had ruled out diabetes before finally ...
A new type of cancer cell that "warrants urgent investigation" has been discovered in childhood leukemia and could impact clinical care. Research into new or repurposed treatments that target this new cell type could give ...
Cervical cancer, which affects the reproductive tract, is one of the most common cancers in women worldwide. It is primarily caused by human papillomavirus (HPV), a viral infection that spreads through sexual contact.
1.
Combination therapy improves outcomes for advanced triple-negative breast cancer
2.
A single bout of exercise gives results that could help cancer patients
3.
FDA Approves Hemophilia B Second Gene Therapy.
4.
New therapeutic strategies raised to prevent and resist metastasis in lymph nodes of breast cancer
5.
A promising medication could slow brain tumors in children.
1.
Breast Cancer Recovery: Fashion, Function, and Healing Beyond Scars
2.
AI on the Front Lines: Revolutionizing Breast Cancer Detection with Artificial Intelligence
3.
Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After
4.
Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review
5.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
3.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
5.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation